1. Home
  2. FET vs ALT Comparison

FET vs ALT Comparison

Compare FET & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

N/A

Current Price

$54.88

Market Cap

514.7M

Sector

Industrials

ML Signal

N/A

Logo Altimmune Inc.

ALT

Altimmune Inc.

N/A

Current Price

$3.59

Market Cap

415.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FET
ALT
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
514.7M
415.3M
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
FET
ALT
Price
$54.88
$3.59
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$15.50
AVG Volume (30 Days)
257.7K
2.9M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
92.64
25.37
EPS
N/A
N/A
Revenue
$791,474,000.00
$41,000.00
Revenue This Year
$4.23
N/A
Revenue Next Year
$9.75
$756,308.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.00
52 Week Low
$12.78
$2.91
52 Week High
$63.58
$7.73

Technical Indicators

Market Signals
Indicator
FET
ALT
Relative Strength Index (RSI) 53.11 35.87
Support Level $25.54 $3.40
Resistance Level $63.58 $4.25
Average True Range (ATR) 2.89 0.23
MACD -0.90 -0.05
Stochastic Oscillator 13.77 16.38

Price Performance

Historical Comparison
FET
ALT

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: